Halo Pharma Inc - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Halo Pharma Inc (Halo) is a contract development and manufacturing organization which offers scientific and development expertise services. It offers project management, formulation development and analytical development services. The organization holds specialization in the development of mini and micro tablets, pellets, beads, powders, capsules, stick pack, liquid suspensions, semi-solid ointments, gels and creams, among others. Halo also offers solids, liquids and sterile ointment; and packaging services. The company offers testing services through contract development, during commercial manufacturing; and throughout the product lifecycle to support manufacturing. Its dosage forms comprise sterile, ophthalmic ointments and topical gels, non-sterile, controlled drugs, and others. Halo is headquartered in Whippany, New Jersey, the US.

Halo Pharma Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Halo Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deal Details 9
Asset Purchase 9
Halo Pharma Completes Acquisition Of Mirabel Manufacturing Facility From Teva Canada 9
Private Equity 10
SK Capital Acquires Majority Stake in Halo Pharma 10
Partnerships 11
ExxPharma Therapeutics Enters into Agreement with Halo Pharma 11
Acquisition 12
Cambrex to Acquire Halo Pharma from SK Capital Partners for USD425 Million 12
Halo Pharma Acquires Minority Stake In Altus Formulation 14
Halo Pharma Inc - Key Competitors 15
Halo Pharma Inc - Key Employees 16
Halo Pharma Inc - Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Corporate Communications 18
Jun 27, 2017: Halo Pharma Welcomes Itzhak Krinsky, Ph.D. to Its Board of Directors 18
Other Significant Developments 19
May 10, 2017: Halo Pharma Announces the Formation of Its Pediatric Center of Excellence for the Development, Reformulation, and Manufacturing of Drug Products in Pediatric Dosage Forms 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List Of Tables


Halo Pharma Inc, Pharmaceuticals & Healthcare, Key Facts 2
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Halo Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Halo Pharma Completes Acquisition Of Mirabel Manufacturing Facility From Teva Canada 9
SK Capital Acquires Majority Stake in Halo Pharma 10
ExxPharma Therapeutics Enters into Agreement with Halo Pharma 11
Cambrex to Acquire Halo Pharma from SK Capital Partners for USD425 Million 12
Halo Pharma Acquires Minority Stake In Altus Formulation 14
Halo Pharma Inc, Key Competitors 15
Halo Pharma Inc, Key Employees 16
Halo Pharma Inc, Subsidiaries 17

List Of Figures


Halo Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Halo Pharma Inc - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Halo Pharma Inc (Halo) is a contract development and manufacturing organization which offers scientific and development expertise services. It offers project management, formulation development and analytical development services. The organization

USD 250 View Report

Halozyme Therapeutics Inc (HALO) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Halozyme Therapeutics Inc (Halozyme) is a biotechnology company that develops and commercializes novel recombinant human enzymes to provide innovative products for cancer, dermatology, diabetes and drug delivery markets. The companys

USD 250 View Report

United BioPharma Inc (6471) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

United BioPharma Inc (United BioPharma) is a pharmaceutical company. The company develops, manufactures, and markets monoclonal antibody (mAb) products and biosimilar antibodies. Its molecules product pipeline includes UB-421, a monoclonal

USD 250 View Report

Nuvelution Pharma Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Nuvelution Pharma Inc (Nuvelution Pharma) is a developer of late-stage clinical assets. The company offers research and development risk-sharing approach to pharmaceutical and biotechnology companies. It facilitates advancement of late-stage

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available